Does Brincidofovir Interact with Rifampin?
Brincidofovir and Rifampin have a moderate drug interaction according to U.S. FDA drug labeling data. OATP1B1/1B3 inhibitor (single dose) increases brincidofovir AUC and Cmax, may increase adverse reactions. Monitor for elevations in transaminases, bilirubin, diarrhea, or GI events. The mechanism involves oatp1b1 and 1b3 inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Rifampin Class
- Rifamycin Antibacterial
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Brincidofovir and Rifampin occurs because oatp1b1 and 1b3 inhibition. Clinically, this means oatp1b1/1b3 inhibitor (single dose) increases brincidofovir auc and cmax, may increase adverse reactions. monitor for elevations in transaminases, bilirubin, diarrhea, or gi events. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Brincidofovir and your doctor is considering prescribing Rifampin (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider